A case of autoimmune hepatitis treated with rituximab

Case Reports in Gastroenterology

Volumn 4, Issue 3, 2010, Pages 502-509

  Barth, E ^a   Clawson, J ^a  

^a Lackland AFB ^*  (United States)

Author keywords

Autoimmune; Hepatitis; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CD20 ANTIGEN; IMMUNOGLOBULIN G; PREDNISONE; RITUXIMAB;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; CASE REPORT; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HEPATOMEGALY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FIBROSIS; LYMPH NODE BIOPSY; MARGINAL ZONE LYMPHOMA; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REMISSION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 78751469089     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000322693     Document Type: Article

References (17)

1. Waldenstrom J: The diagnostic importance of ACTH. Acta Endocrinol (Copenh) 1950;5:235-242.
2. Manns MP, Vogel A: Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006;43(2 suppl 1): S132-S144.
3. Krawitt EL: Autoimmune hepatitis. N Engl J Med 2006;354:54-66.
4. Murray-Lyon IM, Stern RB, Williams R: Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973;i:735-737.
5. Schalm SW, Ammon HV, Summerskill WH: Failure of customary treatment in chronic active liver disease: Causes and management. Ann Clin Res 1976;8:221-227.
6. Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G: Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002;6:727-737.
7. Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, Stedman CA: Population-based epidemiology study of autoimmune hepatitis: A disease of older women? J Gastroenterol Hepatol 2010;25:1681-1686.
8. Alvarez F, Berg PA, Bianchi RB, et al: International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
9. Czaja AJ: Diverse manifestations and evolving treatments of autoimmune hepatitis. Miverna Gastroenterol Dietol 2005;51:313-333.
10. Dienes HP, Popper H, Manns M, Baumann W, Thoenes W, Meyer Zum Buschenfelde KH: Histological features in autoimmune hepatitis. Z Gastroenterol 1989;27:325-330.
11. Vergani D, Alvarez F, Bianchi RB, et al: Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683.
12. Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am J Gastroenterol 1995;90:1206-1211.
13. Homberg JC, Abuaf N, Bernard O, et al: Chronic active hepatitis associated with anti liver/kidney microsome type 1: A second type of 'autoimmune' hepatitis. Hepatology 1987;7:1333-1339.
14. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: Dose titration, standard dose and combination with azathioprine compound. Gut 1975;16:876-883.
15. Czaja AJ: Treatment strategies in autoimmune hepatitis. Clin Liver Dis 2002;6:799-824.
16. Cooper N, Arnold DM: The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol 2010;149:3-13.
17. Ayata G, Gordon FD, Lewis WD, et al: Liver transplantation for autoimmune hepatitis: A long-term pathologic study. Hepatology 2000;32:185-192.